Use of methylphenidate in patients with cancer

Amit Sood, Debra L. Barton, Charles L. Loprinzi

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations


Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer. Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer. Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer. The present article reviews the evidence base behind the use of methylphenidate in these patients.

Original languageEnglish (US)
Pages (from-to)35-40
Number of pages6
JournalAmerican Journal of Hospice and Palliative Medicine
Issue number1
StatePublished - 2006


  • Cancer
  • Fatigue
  • Methylphenidate
  • Palliative care

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Use of methylphenidate in patients with cancer'. Together they form a unique fingerprint.

Cite this